91 related articles for article (PubMed ID: 20506373)
1. Novel immunogenic antigens increase classification accuracy in meningioma to 93.84%.
Ludwig N; Keller A; Heisel S; Leidinger P; Rheinheimer S; Andres C; Stephan B; Steudel WI; Donauer E; Graf N; Burgeth B; Weickert J; Lenhof HP; Meese E
Int J Cancer; 2011 Mar; 128(6):1493-501. PubMed ID: 20506373
[TBL] [Abstract][Full Text] [Related]
2. Elevated serum IL-17A but not IL-6 in glioma versus meningioma and schwannoma.
Doroudchi M; Pishe ZG; Malekzadeh M; Golmoghaddam H; Taghipour M; Ghaderi A
Asian Pac J Cancer Prev; 2013; 14(9):5225-30. PubMed ID: 24175805
[TBL] [Abstract][Full Text] [Related]
3. MGEA6 is tumor-specific overexpressed and frequently recognized by patient-serum antibodies.
Comtesse N; Niedermayer I; Glass B; Heckel D; Maldener E; Nastainczyk W; Feiden W; Meese E
Oncogene; 2002 Jan; 21(2):239-47. PubMed ID: 11803467
[TBL] [Abstract][Full Text] [Related]
4. Five novel immunogenic antigens in meningioma: cloning, expression analysis, and chromosomal mapping.
Comtesse N; Heckel D; Rácz A; Brass N; Glass B; Meese E
Clin Cancer Res; 1999 Nov; 5(11):3560-8. PubMed ID: 10589772
[TBL] [Abstract][Full Text] [Related]
5. Improving seroreactivity-based detection of glioma.
Ludwig N; Keller A; Heisel S; Leidinger P; Klein V; Rheinheimer S; Andres CU; Stephan B; Steudel WI; Graf NM; Burgeth B; Weickert J; Lenhof HP; Meese E
Neoplasia; 2009 Dec; 11(12):1383-9. PubMed ID: 20019846
[TBL] [Abstract][Full Text] [Related]
6. Secretion and immunogenicity of the meningioma-associated antigen TXNDC16.
Harz C; Ludwig N; Lang S; Werner TV; Galata V; Backes C; Schmitt K; Nickels R; Krause E; Jung M; Rettig J; Keller A; Menger M; Zimmermann R; Meese E
J Immunol; 2014 Sep; 193(6):3146-54. PubMed ID: 25122923
[TBL] [Abstract][Full Text] [Related]
7. Tumor-associated autoantibody signature for the early detection of gastric cancer.
Zayakin P; Ancāns G; Siliņa K; Meistere I; Kalniņa Z; Andrejeva D; Endzeliņš E; Ivanova L; Pismennaja A; Ruskule A; Doniņa S; Wex T; Malfertheiner P; Leja M; Linē A
Int J Cancer; 2013 Jan; 132(1):137-47. PubMed ID: 22684876
[TBL] [Abstract][Full Text] [Related]
8. Autologous antibodies to meningioma cell surface antigens.
Pfreundschuh M; Röhrich M; Piotrowksi W; Penzholz H; Fischer H
Anticancer Res; 1981; 1(6):367-72. PubMed ID: 6284017
[TBL] [Abstract][Full Text] [Related]
9. Novel tankyrase-related gene detected with meningioma-specific sera.
Monz D; Munnia A; Comtesse N; Fischer U; Steudel WI; Feiden W; Glass B; Meese EU
Clin Cancer Res; 2001 Jan; 7(1):113-9. PubMed ID: 11205898
[TBL] [Abstract][Full Text] [Related]
10. Combining gene expression signatures and autoantibody profiles in human meningioma.
Keller A; Ludwig N; Comtesse N; Henn W; Steudel WI; Lenhof HP; Meese E
Gene Ther; 2009 Feb; 16(2):184-9. PubMed ID: 18701916
[TBL] [Abstract][Full Text] [Related]
11. Serum Levels of APRIL Increase in Patients with Glioma, Meningioma and Schwannoma.
Fouladseresht H; Ziaee SM; Erfani N; Doroudchi M
Asian Pac J Cancer Prev; 2019 Mar; 20(3):751-756. PubMed ID: 30909681
[TBL] [Abstract][Full Text] [Related]
12. Case-control study of neuroepithelial tumors in Rochester, Minnesota, 1950-1977.
Codd MB; Kurland LT; O'Fallon WM; Beard CM; Cascino TL
Neuroepidemiology; 1990; 9(1):17-26. PubMed ID: 2330067
[TBL] [Abstract][Full Text] [Related]
13. A minimally invasive multiple marker approach allows highly efficient detection of meningioma tumors.
Keller A; Ludwig N; Comtesse N; Hildebrandt A; Meese E; Lenhof HP
BMC Bioinformatics; 2006 Dec; 7():539. PubMed ID: 17184519
[TBL] [Abstract][Full Text] [Related]
14. Complex humoral immune response against a benign tumor: frequent antibody response against specific antigens as diagnostic targets.
Comtesse N; Zippel A; Walle S; Monz D; Backes C; Fischer U; Mayer J; Ludwig N; Hildebrandt A; Keller A; Steudel WI; Lenhof HP; Meese E
Proc Natl Acad Sci U S A; 2005 Jul; 102(27):9601-6. PubMed ID: 15983380
[TBL] [Abstract][Full Text] [Related]
15. Meningioma: is there an association with human leukocyte antigens?
Machulla HK; Steinborn F; Tschigrjai M; Langner J; Rainov NG
Cancer Epidemiol Biomarkers Prev; 2003 Dec; 12(12):1438-42. PubMed ID: 14693734
[TBL] [Abstract][Full Text] [Related]
16. Detection of common antigens in primary and recurrent human meningiomas by radioimmunoassays and other serologic tests.
Winters WD
Cancer Detect Prev; 1983; 6(1-2):325-31. PubMed ID: 6883390
[TBL] [Abstract][Full Text] [Related]
17. Multicenter study identified molecular blood-born protein signatures for Wilms Tumor.
Schmitt J; Heisel S; Keller A; Leidinger P; Ludwig N; Habel N; Furtwängler R; Nourkami-Tutdibi N; Wegert J; Grundy P; Gessler M; Graf N; Lenhof HP; Meese E
Int J Cancer; 2012 Aug; 131(3):673-82. PubMed ID: 21913182
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the humoral response of meningioma patients to possible common tumour-associated antigens.
Mottet S; Martin-Achard A; de Tribolet N; Diserens AC
Acta Neurochir (Wien); 1980; 52(1-2):19-25. PubMed ID: 7376941
[TBL] [Abstract][Full Text] [Related]
19. Prognostic role of high sensitivity C-reactive protein and interleukin-6 in glioma and meningioma patients.
Bunevicius A; Radziunas A; Tamasauskas S; Tamasauskas A; Laws ER; Iervasi G; Bunevicius R; Deltuva V
J Neurooncol; 2018 Jun; 138(2):351-358. PubMed ID: 29460097
[TBL] [Abstract][Full Text] [Related]
20. Multiple serological biomarkers for colorectal cancer detection.
Chan CC; Fan CW; Kuo YB; Chen YH; Chang PY; Chen KT; Hung RP; Chan EC
Int J Cancer; 2010 Apr; 126(7):1683-90. PubMed ID: 19795454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
